162 related articles for article (PubMed ID: 32530885)
1. Long-term Buprenorphine Treatment for Loperamide Use Disorder: A Case Series.
Brar JK; Broyan VR; Allgaier JT; Nye L; Saxon AJ
J Addict Med; 2020 Dec; 14(6):e378-e381. PubMed ID: 32530885
[TBL] [Abstract][Full Text] [Related]
2. Loperamide-Associated Opioid Use Disorder and Proposal of an Alternative Treatment with Buprenorphine.
Wolfrum LA; Nordmeyer AS; Racine CW; Nichols SD
J Addict Med; 2019; 13(3):245-247. PubMed ID: 30379781
[TBL] [Abstract][Full Text] [Related]
3. Management of loperamide-related opioid use disorder with buprenorphine within an Australian context: A case report.
Dunn A; Wu N; Cordaro F
Drug Alcohol Rev; 2024 May; ():. PubMed ID: 38721656
[TBL] [Abstract][Full Text] [Related]
4. Buprenorphine Microdosing Cross Tapers: A Time for Change.
Raheemullah A; Benhamou OM; Kuo J; Lembke A
Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554317
[TBL] [Abstract][Full Text] [Related]
5. Tariquidar, a selective P-glycoprotein inhibitor, does not potentiate loperamide's opioid brain effects in humans despite full inhibition of lymphocyte P-glycoprotein.
Kurnik D; Sofowora GG; Donahue JP; Nair UB; Wilkinson GR; Wood AJ; Muszkat M
Anesthesiology; 2008 Dec; 109(6):1092-9. PubMed ID: 19034106
[TBL] [Abstract][Full Text] [Related]
6. Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: a retrospective cohort study.
Jones BLH; Geier M; Neuhaus J; Coffin PO; Snyder HR; Soran CS; Knight KR; Suen LW
Harm Reduct J; 2024 Apr; 21(1):80. PubMed ID: 38594721
[TBL] [Abstract][Full Text] [Related]
7. The importance of buprenorphine research in the opioid crisis.
Pendergrass SA; Crist RC; Jones LK; Hoch JR; Berrettini WH
Mol Psychiatry; 2019 May; 24(5):626-632. PubMed ID: 30617273
[TBL] [Abstract][Full Text] [Related]
8. Rapid micro-induction of buprenorphine/naloxone for opioid use disorder in an inpatient setting: A case series.
Klaire S; Zivanovic R; Barbic SP; Sandhu R; Mathew N; Azar P
Am J Addict; 2019 Jul; 28(4):262-265. PubMed ID: 30901127
[TBL] [Abstract][Full Text] [Related]
9. Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting.
Cisewski DH; Santos C; Koyfman A; Long B
Am J Emerg Med; 2019 Jan; 37(1):143-150. PubMed ID: 30355476
[TBL] [Abstract][Full Text] [Related]
10. Transition From Methadone to Buprenorphine Using a Short-acting Agonist Bridge in the Inpatient Setting: A Case Study.
Callan J; Pytell J; Ross J; Rastegar DA
J Addict Med; 2020; 14(5):e274-e276. PubMed ID: 31977358
[TBL] [Abstract][Full Text] [Related]
11. The unsuspected threat of three opioid-like substitutes.
Kim S
Arch Psychiatr Nurs; 2019 Aug; 33(4):325-328. PubMed ID: 31280775
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial.
Dunn KE; Tompkins DA; Bigelow GE; Strain EC
JAMA Psychiatry; 2017 Sep; 74(9):885-893. PubMed ID: 28700791
[TBL] [Abstract][Full Text] [Related]
13. Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review.
Adams KK; Machnicz M; Sobieraj DM
Addict Sci Clin Pract; 2021 Jun; 16(1):36. PubMed ID: 34103087
[TBL] [Abstract][Full Text] [Related]
14. "I just wanted to tell you that loperamide WILL WORK": a web-based study of extra-medical use of loperamide.
Daniulaityte R; Carlson R; Falck R; Cameron D; Perera S; Chen L; Sheth A
Drug Alcohol Depend; 2013 Jun; 130(1-3):241-4. PubMed ID: 23201175
[TBL] [Abstract][Full Text] [Related]
15. Methadone Management of Withdrawal Associated With Loperamide-related Opioid Use Disorder.
Leo RJ; Ghazi MA; Jaziri KS
J Addict Med; 2017; 11(5):402-404. PubMed ID: 28574864
[TBL] [Abstract][Full Text] [Related]
16. Low Dose Initiation of Buprenorphine: A Narrative Review and Practical Approach.
Cohen SM; Weimer MB; Levander XA; Peckham AM; Tetrault JM; Morford KL
J Addict Med; 2022 Jul-Aug 01; 16(4):399-406. PubMed ID: 34954746
[TBL] [Abstract][Full Text] [Related]
17. Case Series: Limited Opioid Withdrawal With Use of Transdermal Buprenorphine to Bridge to Sublingual Buprenorphine in Hospitalized Patients.
Tang VM; Lam-Shang-Leen J; Brothers TD; Hansen K; Caudarella A; Lamba W; Guimond T
Am J Addict; 2020 Jan; 29(1):73-76. PubMed ID: 31626394
[TBL] [Abstract][Full Text] [Related]
18. Loperamide Addiction: Atypical Opioid Use Disorder Treated With Buprenorphine/Naloxone.
Varghese SP; Kumari P; Wijegunaratne H; Yovankin T; Garlapati V; Koola MM
Prim Care Companion CNS Disord; 2019 Jul; 21(4):. PubMed ID: 31274259
[No Abstract] [Full Text] [Related]
19. Loperamide Abuse and Dependence: Clinical Features and Treatment Considerations.
Okusanya A; Li X
J Addict Med; 2018; 12(6):496-498. PubMed ID: 30067552
[TBL] [Abstract][Full Text] [Related]
20. Rapid buprenorphine microdosing for opioid use disorder in a hospitalized patient receiving very high doses of full agonist opioids for acute pain management: Titration, implementation barriers, and strategies to overcomes.
DeWeese JP; Krenz JR; Wakeman SE; Peckham AM
Subst Abus; 2021; 42(4):506-511. PubMed ID: 33945452
[No Abstract] [Full Text] [Related]
[Next] [New Search]
